ATUM

🚀JUST ANNOUNCED: ATUM Launches the discoCHO™ Discovery Cell Line for Rapid and Robust Transient Production of Biologics with Manufacturing in Mind ATUM's new CHO-K1-based discoCHO cell line enables robust transient therapeutic protein expression displaying critical quality attributes similar to those of the stable CHO-K1 manufacturing cell line, miCHO-GS. This advancement in antibody production allows you to bring drugs to market faster, while mitigating risk. For more information on this exciting expansion of our industry-leading ecosystem, read the full release: https://hubs.li/Q02LpWVb0 #Biologics #AntibodyProduction #CellLineProduction #CHOK1

What's in store for pharma in 2025? 🔮 Our chief prognosticator, Claes Gustafsson, predicts the regulatory approval of the first tri-specific antibody, Check out what he other drug development, pharma, and oncology executives have to say in Part 2 of this PharmaVoice round-up! https://hubs.li/Q034vNV_0

Our very own Jennifer A. Codding-Bui, Ph.D., is speaking at Bruker Biosensors' "Biosensors and Friends Symposium" this Thursday, January 30th! In the Bay Area? Make sure you don't miss her thought-provoking talk on "AI and SPR for mAB-like Molecules." Register today! Date: January 30, 2025Time: 05:00 pm – 09:00 pm Registration: Free but mandatory, places limited: https://hubs.li/Q034k2pk0 #ProteinEngineering #Bioengineering

Did you miss Sridhar Govindarajan's awesome presentation at #BioLogicSummit/ #PepTalk yesterday? No worries! Swing by *Booth 401* to learn all about how ATUM’s machine learning platform, algorithms, and user-friendly Laboratory Information Management System can help you go from virtual sequence to MCB with just a click! We can't wait to see you there! #AntibodyEngineering Cambridge Innovation Institute

Excited for TODAY at #BioLogicSummit/#PepTalk! 🎉 Don’t miss ATUM’s CIO, Sridhar Govindarajan, talking about 'Bridging AI, Experimental Designs, and Developability' at 4:10 PM PST. Swing by Booth #401 to chat with Selena Larkin, our Chief Commercial Officer, Pedram Sattari, VP of Global Sales, Mario Ribas, Director of Business Development, and of course, Sridhar! We’re super proud to sponsor the first-ever BioLogic Summit! 🙌 #AntibodyEngineering Cambridge Innovation Institute

When the going gets tough, the tough get going. Dominic Esposito and team from the Protein Expression Lab at Frederick National Laboratory for Cancer Research in an heroic effort expressed, purified and sorted out the structure and complex formation of KRAS, RRAS2, and MRAS bound to the catalytic subunit of PI3Kα. Step towards elucidating the PI3K-AKT-mTOR pathway and the cure for cancer. Genes designed and made by your friends at ATUM. https://lnkd.in/g34edwvs

Heading to San Diego for #BioLogicSummit and #PepTalk? 🌴 Dance on over to the Indigo Ballroom to connect with #TeamATUM and hear more about our latest hit, discoCHO™. Don't forget to mark your calendar for Wednesday's presentation on "Optimizing Antibodies & Related Protein Therapeutics: Bridging AI, Experimental Designs, and Developability" with CIO & Co-Founder Sridhar Govindarajan, PhD—you won't want to miss the latest ATUM innovations! ATUM is proud to be a corporate sponsor of the inaugural BioLogic Summit!

A rapid and robust CHO-K1 transient production platform with manufacturing in mind! Discover ATUM’s discoCHO™ 👇👇👇

#BioLogicSummit 2025 in San Diego: Don't miss Sridhar Govindarajan's presentation on 📣 Optimizing Antibodies and Related Protein Therapeutics: Bridging AI, Experimental Designs and Developability 📅 Wednesday, January 15, 2025 🕗 4:10-4:40 PM PST 📍Hilton Backbay, San Diego Register now: https://hubs.li/Q03141TG0 #CellLineDevelopment #Biologics #AntibodyEng Cambridge Innovation Institute

🎄Ready to get your Optimization of Eggnog using Rational Engineering and Design of Experiment eggnog on? Click the link. https://hubs.li/Q030z8Q40 Also, we will be closed Tuesday and Wednesday in observance of the holiday. We'll hop back to it on Thursday, December 26th. Happy Holidays!